How to use diuretics in heart failure (Q43237412)

17 November 2017

How to use diuretics in heart failure (English)

1 reference

17 November 2017

2

G Michael Felker

1 reference

17 November 2017

Elizabeth M Volz

1

1 reference

17 November 2017

1 December 2009

1 reference

Current treatment options in cardiovascular medicine

17 November 2017

1 reference

17 November 2017

11

1 reference

17 November 2017

6

1 reference

17 November 2017

426-432

1 reference

https://scigraph.springernature.com/pub.10.1007/s11936-009-0045-1

17 November 2017

0 references

cites work

Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11936-009-0045-1

2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration

21 January 2018

1 reference

12 December 2020

Mechanism of impaired natriuretic response to furosemide during prolonged therapy

1 reference

12 December 2020

BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy

1 reference

12 December 2020

Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

1 reference

12 December 2020

Diuretic therapy and resistance in congestive heart failure

1 reference

12 December 2020

Structural adaptation of the distal convoluted tubule to prolonged furosemide treatment

1 reference

12 December 2020

Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods

1 reference

12 December 2020

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

1 reference

12 December 2020

Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure.

1 reference

12 December 2020

Continuous infusion versus bolus injection of loop diuretics in congestive heart failure

1 reference

12 December 2020

Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study

1 reference

12 December 2020

Interaction between nonsteroidal anti-inflammatory drugs and loop diuretics: modulation by sodium balance

1 reference

12 December 2020

The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment

1 reference

12 December 2020

Combination diuretic treatment in severe heart failure: a randomised controlled trial

1 reference

12 December 2020

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

12 December 2020

Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction

1 reference

12 December 2020

Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial

1 reference

12 December 2020

Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial

1 reference

12 December 2020

Loop diuretics in acute decompensated heart failure: necessary? Evil? A necessary evil?

1 reference

12 December 2020

Relationship between heart failure treatment and development of worsening renal function among hospitalized patients

1 reference

12 December 2020

2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

1 reference

12 December 2020

Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials

1 reference

12 December 2020

Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD)

1 reference

12 December 2020

10.1007/S11936-009-0045-1

Identifiers

DOI

1 reference

PubMed ID

19930980

Dimensions Publication ID

17 November 2017

0 references

1 reference

PubMed ID

19930980